Skip to main content
Livermore
Livermore
ZHEN

Alliancebernstein L.P.

SEC CIK
0001109448
Latest filing
Aug 14, 2026

ITOS holding history

iTeos Therapeutics, Inc. in every 13F filed by Alliancebernstein L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITOS overviewAll 13F holders of ITOSFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ITOS by Alliancebernstein L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−44,180−100.0%Sold outHolders
Q2 202544,180$440.5K<0.1%+11,670+35.9%AddedHolders
Q1 202532,510$194.1K<0.1%00.0%UnchangedHolders
Q4 202432,510$249.7K<0.1%00.0%UnchangedHolders
Q3 202432,510$331.9K<0.1%−5,900−15.4%ReducedHolders
Q2 202438,410$570.0K<0.1%+6,580+20.7%AddedHolders
Q1 202431,830$434.2K<0.1%−3,490−9.9%ReducedHolders
Q4 202335,320$386.8K<0.1%00.0%UnchangedHolders
Q3 202335,320$386.8K<0.1%−1,740−4.7%ReducedHolders
Q2 202337,060$490.7K<0.1%+11,760+46.5%AddedHolders
Q1 202325,300$344.3K<0.1%−3,622−12.5%ReducedHolders
Q4 202228,922$564.8K<0.1%−43,857−60.3%ReducedHolders
Q3 202272,779$1.39M<0.1%−558,339−88.5%ReducedHolders
Q2 2022631,118$13.0M<0.1%−486,228−43.5%ReducedHolders
Q1 20221,117,346$36.0M<0.1%−187,867−14.4%ReducedHolders
Q4 20211,305,213$60.8M<0.1%−29,868−2.2%ReducedHolders
Q3 20211,335,081$36.0M<0.1%−19,997−1.5%ReducedHolders
Q2 20211,355,078$34.8M<0.1%+185,077+15.8%AddedHolders
Q1 20211,170,001$40.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.